Devices

Galimedix, Inc. Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation The issuer is solely responsible for the content of this announcement. Galimedix …

Word Count: 4,112 words, Reading Time: 19 minutes. Not financial advice, do your own due diligence, for entertainment purposes only. Subscribers: Substack is telling me this …

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025 Rancho Cucamonga, 02/26/2026 / 13:05, PST/PDT – EQS Newswire – …

Word Count: 3,865 words, Reading Time: 18 minutes. Not financial advice, do your own due diligence, for entertainment purposes only. Subscribers: Substack is telling me this …

Rezpeg incorporates a novel mechanism of action that has proven thus far to be safe and efficacious. It represents not just a single therapy but a …

Word Count: 4,091 words, Reading Time: 19 minutes. Not financial advice, do your own due diligence, for entertainment purposes only. Subscribers: Substack is telling me this …

Word Count: 2,400 words, Reading Time: 11 minutes. Not financial advice, do your own due diligence, for entertainment purposes only. Subscribers: Substack is telling me this …

Filed by Movano Inc.pursuant to Rule 425 under the Securities Act of 1933and deemed filed pursuant to Rule 14a-12under the Securities Exchange Act of 1934Subject Company: …

Word Count: 3,624 words, Reading Time: 16 minutes. Not financial advice, do your own due diligence, for entertainment purposes only. Subscribers: Substack is telling me this …

VALBIOTIS SA: Valbiotis announces an exclusive distribution agreement in the Middle East The issuer is solely responsible for the content of this announcement.   Valbiotis announces an …